Evaluating cell lines as tumour models by comparison of genomic profiles

被引:1070
作者
Domcke, Silvia [1 ,2 ]
Sinha, Rileen [1 ]
Levine, Douglas A. [3 ]
Sander, Chris [1 ]
Schultz, Nikolaus [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA
[2] Tech Univ Munich, Dept Chem, D-85747 Garching, Germany
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA
关键词
GRADE SEROUS CARCINOMA; FOLATE RECEPTOR GENE; OVARIAN-CANCER; IN-VITRO; MUTATIONS; EXPRESSION; PIK3CA; ENDOMETRIAL; EVOLUTION; FEATURES;
D O I
10.1038/ncomms3126
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cancer cell lines are frequently used as in vitro tumour models. Recent molecular profiles of hundreds of cell lines from The Cancer Cell Line Encyclopedia and thousands of tumour samples from the Cancer Genome Atlas now allow a systematic genomic comparison of cell lines and tumours. Here we analyse a panel of 47 ovarian cancer cell lines and identify those that have the highest genetic similarity to ovarian tumours. Our comparison of copy-number changes, mutations and mRNA expression profiles reveals pronounced differences in molecular profiles between commonly used ovarian cancer cell lines and high-grade serous ovarian cancer tumour samples. We identify several rarely used cell lines that more closely resemble cognate tumour profiles than commonly used cell lines, and we propose these lines as the most suitable models of ovarian cancer. Our results indicate that the gap between cell lines and tumours can be bridged by genomically informed choices of cell line models for all tumour types.
引用
收藏
页数:10
相关论文
共 60 条
[31]   The peritoneal tumour microenvironment of high-grade serous ovarian cancer [J].
Leinster, D. Andrew ;
Kulbe, Hagen ;
Everitt, Gemma ;
Thompson, Richard ;
Perretti, Mauro ;
Gavins, Felicity N. E. ;
Cooper, Dianne ;
Gould, David ;
Ennis, Darren P. ;
Lockley, Michelle ;
McNeish, Iain A. ;
Nourshargh, Sussan ;
Balkwill, Frances R. .
JOURNAL OF PATHOLOGY, 2012, 227 (02) :136-145
[32]   Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer [J].
Liu, JS ;
Albarracin, CT ;
Chang, KH ;
Thompson-Lanza, JA ;
Zheng, WX ;
Gershenson, DM ;
Broaddus, R ;
Luthra, R .
MODERN PATHOLOGY, 2004, 17 (01) :75-80
[33]   A global map of human gene expression [J].
Lukk, Margus ;
Kapushesky, Misha ;
Nikkila, Janne ;
Parkinson, Helen ;
Goncalves, Angela ;
Huber, Wolfgang ;
Ukkonen, Esko ;
Brazma, Alvis .
NATURE BIOTECHNOLOGY, 2010, 28 (04) :322-324
[34]   Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma [J].
Macor, P ;
Mezzanzanica, D ;
Cossetti, C ;
Alberti, P ;
Figini, M ;
Canevari, S ;
Tedesco, F .
CANCER RESEARCH, 2006, 66 (07) :3876-3883
[35]   Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma [J].
Madore, Jason ;
Ren, Fengge ;
Filali-Mouhim, Ali ;
Sanchez, Lilia ;
Koebel, Martin ;
Tonin, Patricia N. ;
Huntsman, David ;
Provencher, Diane M. ;
Mes-Masson, Anne-Marie .
JOURNAL OF PATHOLOGY, 2010, 220 (03) :392-400
[36]  
Mangiarotti F, 2001, J CELL BIOCHEM, V81, P488, DOI 10.1002/1097-4644(20010601)81:3<488::AID-JCB1062>3.0.CO
[37]  
2-4
[38]   CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma [J].
Mezzanzanica, D ;
Balladore, E ;
Turatti, F ;
Luison, E ;
Alberti, P ;
Bagnoli, M ;
Figini, M ;
Mazzoni, A ;
Raspagliesi, F ;
Oggionni, M ;
Pilotti, S ;
Canevari, S .
CLINICAL CANCER RESEARCH, 2004, 10 (15) :5202-5214
[39]  
Motoyama T, 1982, Nihon Sanka Fujinka Gakkai Zasshi, V34, P308
[40]  
MOTOYAMA T, 1981, ACTA OBSTET GYN JPN, V33, P1197